Wednesday, April 27, 2016

The promises at CRBCM

Dear Dr. Kankonde,

We will forward the kits for HLA typing of his sibs.
I will inform our Cell and Gene therapy unit.


From Baylor University to CRBCM

2:42 PM (18 hours ago)

"Augmented Hyper-CVAD based on dose-Intensified Vincristine, Dexamethasone, and Asparaginase Therapy"  Katarjian et al...

This is what Baylor University has recommended for our patient with refractory ALL. (peristant MRD)  we thank them...
Post a Comment